Dyadic International (DYAI) Exchange Rate Effect (2018 - 2026)
Dyadic International's (DYAI) quarterly Exchange Rate Effect came in at -$633.0 in Q1 2026, down 140.34% year-over-year from $1569.0 in Q1 2025, and down 88.39% quarter-over-quarter from -$336.0 in Q4 2025.
Powered by 
Analysis
Dyadic International (DYAI) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Dyadic International has disclosed Exchange Rate Effect across 9 years of filings, most recently posting -$633.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 140.34% year-over-year to -$633.0; the TTM figure through Mar 2026 stood at -$261.0 (up 89.86% YoY), while the FY2025 annual figure was $1941.0, up 133.49% from the prior year.
- Exchange Rate Effect came in at -$633.0 for Q1 2026 at Dyadic International, down from -$336.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1569.0 in Q1 2025 to a low of -$22501.0 in Q4 2022.
- Average Exchange Rate Effect over 5 years is -$3036.3, with a median of -$484.0 recorded in 2023.
- Year-over-year, Exchange Rate Effect sank 656.12% in 2024 and surged 194.86% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$22501.0 in 2022, then surged by 104.79% to $1078.0 in 2023, then slumped by 656.12% to -$5995.0 in 2024, then jumped by 94.4% to -$336.0 in 2025, then plunged by 88.39% to -$633.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$633.0 in Q1 2026, -$336.0 in Q4 2025, and -$416.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.38 Bn | 192.39 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.22 Bn | 177.04 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.42 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.97 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.49 Bn | 55.30 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.90 Bn | 48.76 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.11 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | 315,000.00 |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - | -633.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -633.00 |
| Dec 31, 2025 | -336.00 |
| Sep 30, 2025 | -416.00 |
| Jun 30, 2025 | 1,124.00 |
| Mar 31, 2025 | 1,569.00 |
| Dec 31, 2024 | -5,995.00 |
| Sep 30, 2024 | 1,250.00 |
| Jun 30, 2024 | 603.00 |
| Mar 31, 2024 | -1,654.00 |
| Dec 31, 2023 | 1,078.00 |
| Sep 30, 2023 | -4,078.00 |
| Jun 30, 2023 | 1,099.00 |
| Mar 31, 2023 | -484.00 |
| Dec 31, 2022 | -22,501.00 |
| Sep 30, 2022 | -10,895.00 |
| Jun 30, 2022 | -10,780.00 |
| Mar 31, 2022 | -568.00 |
| Dec 31, 2021 | -21,567.00 |
| Sep 30, 2021 | -29,059.00 |
| Jun 30, 2021 | 6.82 Mn |